v1
A phase IA trial of sequential administration recombinant DNA-produced interferons: combination recombinant interferon gamma and recombinant interferon alfa in patients with metastatic renal cell carcinoma.
Identifier:nobleid.org/w1/20260515/2FBAF2BE
Type:Journal Article
0 views
Embeddable Badge
[](https://nobleid.org/work/w1/20260515/2FBAF2BE)
Bibliometric Analysis
Impact metrics, research fronts, co-authorship networks →
Authors & Claims